Literature DB >> 19226263

Novel mutations of the BSCL2 and AGPAT2 genes in 10 families with Berardinelli-Seip congenital generalized lipodystrophy syndrome.

Debora M Miranda1, Bernardo L Wajchenberg, Maria R Calsolari, Marcos J Aguiar, José M C L Silva, Marcia G Ribeiro, Cristina Fonseca, Daniela Amaral, Wolfanga L Boson, Bruna A Resende, Luiz De Marco.   

Abstract

CONTEXT: Congenital generalized lipodystrophy, or Berardinelli-Seip syndrome, is a rare autosomal recessive disease caused by mutations in either the BSCL2 or AGPAT2 genes. This syndrome is characterized by an almost complete loss of adipose tissue usually diagnosed at birth or early infancy resulting in apparent muscle hypertrophy. Common clinical features are acanthosis nigricans, hepatomegaly with or without splenomegaly and high stature. Acromegaloid features, cardiomyopathy and mental retardation can also be present.
DESIGN: We investigated 11 kindreds from different geographical areas of Brazil (northeast and southeast). All coding regions as well as flanking intronic regions of both genes were examined. Polymerase chain reaction (PCR) amplifications were performed using primers described previously and PCR products were sequenced directly.
RESULTS: Four AGPAT2 and two BSCL2 families harboured the same set of mutations. BSCL2 gene mutations were found in the homozygous form in four kindreds (c.412C>T c.464T>C, c.518-519insA, IVS5-2A>G), and in two kindreds compound mutations were found (c.1363C>T, c.424A>G). In the other four families, one mutation of the AGPAT2 gene was found (IVS3-1G>C and c.299G>A).
CONCLUSIONS: We have demonstrated four novel mutations of the BSCL2 and AGPAT2 genes responsible for Berardinelli-Seip syndrome and Brunzell syndrome (AGPAT2-related syndrome).

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19226263     DOI: 10.1111/j.1365-2265.2009.03532.x

Source DB:  PubMed          Journal:  Clin Endocrinol (Oxf)        ISSN: 0300-0664            Impact factor:   3.478


  20 in total

1.  Bone imaging findings in genetic and acquired lipodystrophic syndromes: an imaging study of 24 cases.

Authors:  Stephanie Teboul-Coré; Caroline Rey-Jouvin; Anne Miquel; Camille Vatier; Jacqueline Capeau; Jean-Jacques Robert; Thao Pham; Olivier Lascols; Francis Berenbaum; Jean-Denis Laredo; Corinne Vigouroux; Jérémie Sellam
Journal:  Skeletal Radiol       Date:  2016-09-08       Impact factor: 2.199

2.  Coffee consumption is associated with DNA methylation levels of human blood.

Authors:  Yu-Hsuan Chuang; Austin Quach; Devin Absher; Themistocles Assimes; Steve Horvath; Beate Ritz
Journal:  Eur J Hum Genet       Date:  2017-02-15       Impact factor: 4.246

Review 3.  Seipin: from human disease to molecular mechanism.

Authors:  Bethany R Cartwright; Joel M Goodman
Journal:  J Lipid Res       Date:  2012-04-02       Impact factor: 5.922

4.  Clinical Utility Gene Card for: Congenital Generalized Lipodystrophy.

Authors:  Isabelle Jéru; Camille Vatier; David Araujo-Vilar; Corinne Vigouroux; Olivier Lascols
Journal:  Eur J Hum Genet       Date:  2016-05-18       Impact factor: 4.246

Review 5.  The Complex Roles of Mechanistic Target of Rapamycin in Adipocytes and Beyond.

Authors:  Peter L Lee; Su Myung Jung; David A Guertin
Journal:  Trends Endocrinol Metab       Date:  2017-02-22       Impact factor: 12.015

6.  Natural History of Congenital Generalized Lipodystrophy: A Nationwide Study From Turkey.

Authors:  Baris Akinci; Huseyin Onay; Tevfik Demir; Samim Ozen; Hulya Kayserili; Gulcin Akinci; Banu Nur; Beyhan Tuysuz; Mehmet Nuri Ozbek; Adem Gungor; Ilgin Yildirim Simsir; Canan Altay; Leyla Demir; Enver Simsek; Murat Atmaca; Haluk Topaloglu; Habib Bilen; Hulusi Atmaca; Tahir Atik; Umit Cavdar; Umut Altunoglu; Ayca Aslanger; Ercan Mihci; Mustafa Secil; Fusun Saygili; Abdurrahman Comlekci; Abhimanyu Garg
Journal:  J Clin Endocrinol Metab       Date:  2016-05-04       Impact factor: 5.958

Review 7.  Congenital generalized lipodystrophies--new insights into metabolic dysfunction.

Authors:  Nivedita Patni; Abhimanyu Garg
Journal:  Nat Rev Endocrinol       Date:  2015-08-04       Impact factor: 43.330

8.  Alterations in lipid signaling underlie lipodystrophy secondary to AGPAT2 mutations.

Authors:  Angela R Subauste; Arun K Das; Xiangquan Li; Brandon G Elliott; Brandon Elliot; Charles Evans; Mahmoud El Azzouny; Mary Treutelaar; Elif Oral; Todd Leff; Charles F Burant
Journal:  Diabetes       Date:  2012-08-07       Impact factor: 9.461

9.  Deletion mutation in BSCL2 gene underlies congenital generalized lipodystrophy in a Pakistani family.

Authors:  Obaid Ur Rahman; Nadeem Khawar; Muhammad Aman Khan; Jawad Ahmed; Kamran Khattak; Jumana Yousuf Al-Aama; Muhammad Naeem; Musharraf Jelani
Journal:  Diagn Pathol       Date:  2013-05-09       Impact factor: 2.644

10.  Two novel mutations identified in familial cases with Donohue syndrome.

Authors:  Tzipora C Falik Zaccai; Limor Kalfon; Aharon Klar; Mordechai Ben Elisha; Haggit Hurvitz; Galina Weingarten; Emelia Chechik; Vered Fleisher Sheffer; Raid Haj Yahya; Gal Meidan; Eva Gross-Kieselstein; Dvora Bauman; Sylvia Hershkovitz; Yuval Yaron; Avi Orr-Urtreger; Efrat Wertheimer
Journal:  Mol Genet Genomic Med       Date:  2013-11-14       Impact factor: 2.183

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.